All treatments Treatments

Precision & molecular testing

Guidance on which genetic or biomarker tests are worth doing, and what the results mean for you.

Why test the cancer?

  • Every cancer has its own instruction book, written in its genes and proteins.
  • Tests on the biopsy read parts of this book, to find targets for specific medicines and to predict which treatments will work.
  • Two people with the same cancer, in the same organ and at the same stage, may need very different treatment because of these results.

The main tests

Tap a test to see what it is and what it shows.

From biopsy to treatment plan

This is why we sometimes ask you to wait for all reports before starting treatment.

  1. BiopsyA small piece of the cancer is taken.
  2. PathologyConfirms the cancer and its type (3 to 5 days).
  3. IHC and other stainsER, PR, HER2, PD-L1, MMR (a few days more).
  4. NGS, if neededFor advanced cancer (2 to 3 weeks).
  5. Tumour boardAll results discussed together.
  6. Your planExplained to you and your family.

What a result can mean

ResultWhat it can mean
A target is foundA targeted tablet or drip that works better, or has fewer side effects, than standard chemotherapy.
MSI-high, or high PD-L1 or TMBImmunotherapy is more likely to work.
An inherited mutation is suspectedA blood test for you, and testing for your family.
Nothing treatable is foundStill useful: it avoids medicines that would not work, and standard treatment is chosen. It may make you eligible for a clinical trial.

Practical points

  • These tests are expensive, so we advise the tests that can change your treatment. Please ask us before getting tests done elsewhere.
  • Ask the lab to keep your biopsy blocks and slides; they can be used for more tests later or for a second opinion.
  • Some tests are repeated later, when the cancer changes.

Already on treatment?

Choose your regimen to see the side effects of your own medicines, when to expect them, and what helps.

My treatment

How your treatment is decided

Every new patient's case is discussed at our multidisciplinary tumour board. This is a meeting where the medical oncologist, surgical oncologist, radiation oncologist, radiologist and pathologist, and when needed the nuclear medicine and palliative care teams, review your scans, biopsy and reports together.

  • Cancer treatment often combines surgery, radiotherapy and medicines. The board agrees on the right treatments and the right order.
  • You get one agreed plan, based on the latest evidence, instead of separate opinions.
  • Cases are discussed again when the situation changes, for example after surgery or if a scan shows new findings.

Written and medically reviewed by Dr Prathyusha Eaga, MD, DM (Medical Oncology). Last reviewed: 12 October 2026. Based on NCCN and ESMO guidelines.

Have questions?

Book a hospital visit, a video consultation or a second opinion.